SAN DIEGO — Children with type 1 diabetes who began using a continuous glucose monitor within 6 months of diagnosis had a lower HbA1c at 3 years than those who started CGM 6 to 12 months after diagnosis, according to a speaker. “This multi-institution analysis of more than 10,000 people with type 1 [diabetes] shows long-term HbA1c improvement for individuals able to initiate CGM
SAN DIEGO — Diabetes and nonalcoholic fatty liver disease are “common bedfellows” due to processes brought on by insulin resistance, but a reduction in dietary sugars combined with exercise can reverse the damage, according to a speaker.Diabetes and nonalcoholic fatty liver disease (NAFLD) occur together in populations, Elizabeth Parks, PhD, FAHA, FTOS, professor of nutrition
SAN DIEGO — Adults with obesity and type 2 diabetes achieved a 14.7% weight loss at 72 weeks with 15 mg tirzepatide, according to data from the SURMOUNT-2 trial presented at the American Diabetes Association Scientific Sessions.In a phase 3 randomized controlled trial, more than 60% of adults with obesity and type 2 diabetes lost at least 10% of their body weight at 72 weeks if they were
Gray brings significant biotech financial and operations experience to Carmot to advance a clinical pipeline of therapies to treat people with diabetes and.